Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.
Cancers (Basel). 2020 Apr 10;12(4):924. doi: 10.3390/cancers12040924.
Cancers (Basel). 2020.
PMID: 32290052
Free PMC article.
Review.
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.
Ishibashi M, Sunakawa-Kii M, Kaito Y, Kinoshita R, Asayama T, Kuribayashi Y, Inokuchi K, Morita R, Tamura H.
Ishibashi M, et al. Among authors: sunakawa kii m.
Exp Hematol. 2020 Oct;90:72-79. doi: 10.1016/j.exphem.2020.08.006. Epub 2020 Aug 17.
Exp Hematol. 2020.
PMID: 32818503
Free article.
Item in Clipboard
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.
Kinoshita R, Ishibashi M, Handa H, Sasaki M, Imai Y, Tanaka N, Ito S, Sunakawa-Kii M, Kaito Y, Asayama T, Komatsu N, Tanaka J, Odajima T, Sugimori H, Yamaguchi H, Inokuchi K, Tamura H.
Kinoshita R, et al. Among authors: sunakawa kii m.
Exp Hematol. 2023 May;121:38-47.e2. doi: 10.1016/j.exphem.2023.01.006. Epub 2023 Feb 14.
Exp Hematol. 2023.
PMID: 36796620
Item in Clipboard
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma Cells.
Ishibashi M, Yamamoto J, Ito T, Handa H, Sunakawa-Kii M, Inokuchi K, Morita R, Tamura H.
Ishibashi M, et al. Among authors: sunakawa kii m.
Mol Cancer Ther. 2021 Jul;20(7):1283-1294. doi: 10.1158/1535-7163.MCT-20-0246. Epub 2021 Apr 20.
Mol Cancer Ther. 2021.
PMID: 33879556
Item in Clipboard
Cite
Cite